Bevenopran

Published

dm+d

Unassigned

New Medicines

Opioid-induced constipation

Information

New molecular entity
Not Known
Cubist

Development and Regulatory status

Discontinued
Discontinued
Discontinued
May 15: Following acquisition of Cubist by Merck (MSD), development for this indication was discontinued [1].

Category

Highly peripheralised opioid mu receptor antagonist
Opioid-induced constipation
Oral